Welcome to our dedicated page for HACQ news (Ticker: HACQ), a resource for investors and traders seeking the latest updates and insights on HACQ stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect HACQ's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of HACQ's position in the market.
HCM IV Acquisition Corp (NASDAQ:HACQ) priced a $250.0 million initial public offering of 25,000,000 units at $10.00 per unit on Feb 11, 2026. Each unit contains one Class A ordinary share and one-quarter of a redeemable warrant; whole warrants exercise at $11.50.
Units begin trading on Feb 12, 2026 under ticker HACQU, with Class A shares and warrants expected to trade separately as HACQ and HACQW. Cantor Fitzgerald is sole bookrunner and underwriters have a 45-day option for 3,750,000 additional units.
